Metabolomics Market Analysis

Indication (Cancer, Cardiovascular Disorders, Neurological Disorders)

The global metabolomics market is segmented and analyzed for demand and supply by indication into cancer, cardiovascular disorders, and neurological disorders. Out of these, the cancer segment is anticipated to hold the largest market size by the end of 2037 on account of the rising incidence of cancer patients is expected to boost the market growth. Lung cancer is the leading cause of death in men and women, more than a million new cancer cases and more than 6 million deaths occurred in 2020. Metabolomics application of Nuclear Magnetic Resonance technique and Mass Spectrometry is used to study cancer disease.

Our in-depth analysis of the global metabolomics market includes the following segments:

By Product & Services	Metabolomics Instruments Metabolomics Bioinformatics Tools & Services
By Application	Biomarker Discovery Drug Discovery Toxicology Testing Functional Genomics Personalized Medicine Nutrigenomics
By Indication	Cancer Cardiovascular Disorders Neurological Disorders
By Metabolomics	Separation Techniques Detection Techniques

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of metabolomics is estimated at USD 2.83 billion.

The metabolomics market size was over USD 2.56 billion in 2024 and is poised to cross USD 12.68 billion by the end of 2037, witnessing more than 13.1% CAGR during the forecast period i.e., between 2025-2037. Growing acceptance of metabolomics in personalized medicine, increased incidence of chronic diseases, funding from government and private authorities will boost the market growth.

Asia Pacific is anticipated to dominate majority industry share by 2037, on the back of increasing demand for pharmaceutical and biopharmaceutical products developed in the regions of developing countries such as India and China.

The major players in the market include Thermo Fisher Scientific, Agilent Technologies, Biocrates Life Sciences AG, Bio-Rad Laboratories, Inc., Bruker, Danaher, Human Metabolome Technologies America Inc., LECO Corporation, Metabolon, Inc., Shimadzu Corporation.

Metabolomics Market Analysis